MIRM Mirum Pharmaceuticals, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed Jun 10, 2026 Processed 11d 6h ago
Insider cluster: 3 insiders, $0.9M total
Latest settled — T+5d
MIRM ▲ +8.03% at T+5d
NEUTRAL call ✓ call won +8.03% · α vs SPY +4.60% · entry $94.00 → $101.55
Next anchor: T+20d in 17d
Last close $107.13 (close Jun 18) · +13.97% from $94.00 entry
Entry anchored
Jun 9, 03:59 PM ET
via Databento tick
T+1d
+5.89%
call +5.89% · α +4.19%
$99.54
settled 11d ago
T+5d
+8.03%
call +8.03% · α +4.60%
$101.55
settled 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Three Mirum insiders, including the CEO and CFO, sold a total of $854K in open-market sales over a one-week window. The CFO also exercised and sold shares from option exercises, while the COO exercised options without selling. The sales represent ~0.015% of the $5.7B market cap, well below the 0.1% threshold for materiality, and the cluster includes a mix of cashless exercises and open-market sales, suggesting routine portfolio management rather than a coordinated bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$854.0K
Insiders
3

Actionable Insight

Insider sales are immaterial in dollar terms and likely reflect routine diversification and option exercise tax planning. No bearish signal from this cluster. Monitor next earnings for fundamental updates; the 95% analyst buy rating and strong historical performance suggest continued positive sentiment.

Key Facts

  • CEO Christopher Peetz sold 2.6K shares for $246K on 2026-06-01
  • Director Saira Ramasastry sold 4.0K shares for $398K on 2026-06-01
  • CFO Eric Bjerklolt sold 2.3K shares for $210K on 2026-06-08, following option exercises
  • Total open-market sales: $854K, representing ~0.015% of market cap
  • COO Peter Radovich exercised 16,988 options on 2026-06-05 but did not sell any shares

Financial Impact

Total insider sales of $854K, or ~0.015% of $5.7B market cap — trivial relative to company size

insider ownershipdilution

Risk Factors

  • Insider sales, while small, could be misinterpreted by retail traders as a negative signal
  • The CEO and CFO both sold, which may raise questions if followed by larger sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1781054493725
10 reports for MIRM
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+5▲ +14.39%Apr 27, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
Type Now
Jun 11, 2026
9d ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $102.04▲ +2.51%▲ +2.08%$107.13 (+7.63%)
Jun 10, 2026
11d ago
Insider Cluster
NEUTRAL ★ 3/10
$94.00 $101.55▲ +8.03%▲ +4.60%$107.13 (+13.97%)
Jun 2, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $94.00▲ +2.36%▲ +6.18%$107.13 (+16.65%)
Jun 1, 2026
19d ago
144
NEUTRAL ★ 3/10
$92.17 $95.48▲ +3.59%▲ +6.56%$107.13 (+16.23%)
Jun 1, 2026
19d ago
144
NEUTRAL ★ 2/10
$92.17 $95.48▲ +3.59%▲ +6.56%$107.13 (+16.23%)
May 18, 2026
4w ago
8-K
MIXED ★ 6/10
$95.65 $97.33▲ +1.76%▼ −0.54%$107.13 (+12.00%)
May 4, 2026
6w ago
8-K
BULLISH ★ 6/10
$105.79 $106.17▲ +0.36%▼ −2.58%$107.13 (+1.27%)
Apr 27, 2026
7w ago
8-K
BULLISH ★ 8/10
$92.48 $105.79▲ +14.39%▲ +13.99%$107.13 (+15.84%)
Apr 15, 2026
9w ago
144
NEUTRAL ★ 2/10
$95.86 $91.95▼ −4.08%▼ −5.06%$107.13 (+11.76%)
Feb 25, 2026
16w ago
8-K
BULLISH ★ 8/10
$108.62 $93.04▼ −14.34%▼ −13.24%$107.13 (−1.37%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (29h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access